CIK: 0001012622 · Show all filings
Period: Q2 2019 (← Previous) (Next →)
Filing Date: Aug 14, 2019
Total Value ($000): $464,874 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | QUIDEL CORP | 1,785,264 | $105,902 | 22.8% | $25223.83 | — | COM | 74838J101 |
| — | ACCELERATE DIAGNOSTICS INC | 4,356,363 | $99,674 | 21.4% | $22.26 | — | COM | 00430H102 |
| — | AMARIN CORP PLC | 5,128,970 | $99,451 | 21.4% | $603.60 | — | SPONS ADR NEW | 023111206 |
| — | BIOHAVEN PHARMACTL HLDG CO L | 1,672,950 | $73,258 | 15.8% | $46.97 | — | COM | G11196105 |
| — | DERMIRA INC | 1,760,072 | $16,826 | 3.6% | $12.66 | — | COM | 24983L104 |
| — | MOTUS GI HLDGS INC | 3,766,666 | $11,413 | 2.5% | $3.09 | — | COM | 62014P108 |
| — | SOLENO THERAPEUTICS INC | 3,813,558 | $10,678 | 2.3% | $1.79 | — | COM NEW | 834203200 |
| OPK | OPKO HEALTH INC | 3,686,194 | $8,994 | 1.9% | $7.29 | -70.1% | COM | 68375N103 |
| — | VERMILLION INC | 9,825,289 | $8,745 | 1.9% | $1445.80 | — | COM NEW | 92407M206 |
| — | BIOLASE INC | 5,173,250 | $7,605 | 1.6% | $1.21 | — | COM NEW | 090911207 |
| PACB | PACIFIC BIOSCIENCES CALIF IN | 1,110,666 | $6,720 | 1.4% | $4.84 | +44.9% | COM | 69404D108 |
| CI | CIGNA CORP NEW | 29,653 | $4,672 | 1.0% | $143.34 | 0.0% | COM | 125523100 |
| — | AGENUS INC | 1,408,918 | $4,227 | 0.9% | $2.30 | — | COM NEW | 00847G705 |
| — | CONTRAFECT CORP | 6,356,649 | $3,242 | 0.7% | $2.06 | — | COM | 212326102 |
| BIIB | BIOGEN INC | 6,368 | $1,489 | 0.3% | $213.68 | +8.1% | COM | 09062X103 |
| — | ACCELERATE DIAGNOSTICS INC | 180,000 | $808 | 0.2% | $22.26 | — | Call | 00430H102 |
| — | BIOHAVEN PHARMACTL HLDG CO L | 458,800 | $692 | 0.1% | $46.97 | — | Call | G11196105 |
| — | AMARIN CORP PLC | 650,700 | $478 | 0.1% | $603.60 | — | Call | 023111206 |